Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol

Recruiting now · Not applicable

Conditions studied: Vital, Pulpotomy, Techniques

In brief

Despite the benefit of formocresol, there are toxic effects allergic reactions and local soft and hard tissue necrosis have been reported when such formaldehyde compounds were used clinically, however, the adverse effect of the clinically used of this compound are not widely reported. It has been stated that it has a side effect on the permanent successor although it results as a successful technique for the treatment of the primary teeth

Key facts

Study ID

NCT06288477

Run by

October University for Modern Sciences and Arts

People needed

44

Starts

2024-03-20

Expected to finish

2025-02-01

Last updated by the study team

2024-12-20

Who can join

Age: 4 and older, up to 9. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 4 -9 years old
• Primary molars with no spontaneous or provoked pain
• Primary molars with at least two-thirds of the root length were still present.
• Primary molars with no sign of internal or other kinds of root or bone resorption.

You may not qualify if…

• Patients with systemic diseases (congenital or rheumatic heart disease, hepatitis, nephritis, tumor, cyclic neutropenia, leukemia, and children on long-term corticosteroid therapy).
• Un-cooperative patients.
• Un-restorable primary molars (Grossly broken-down primary molars that have decay extending way under the gingiva and tooth with root caries).

Where it is running

• MSA University — El-Sheikh Zayed City, Giza Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.